While naturally occurring psychedelics have been used by traditional cultures for generations, companies have recently begun to patent psychedelic therapies and compounds inspired by these traditions. This practice has raised questions about who benefits from the current system of intellectual property rights. Join us to hear from visionary thinkers imagining a system of IP that supports innovation and scientific progress while returning benefit and protecting public health.